Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of FUSION ANTIBODIES PLC - ORD 4P
No Price
Closing Price XLON 01.05.2026:
13,67 GBX
01.05.2026 14:38
Current Prices from FUSION ANTIBODIES PLC - ORD 4P
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
London
FAB.L
GBX
01.05.2026 14:38
13,67 GBX
-0,33 GBX
-2,36 %
Share Float & Liquidity
Free Float82,25 %
Shares Float102,82 M
Shares Outstanding125,02 M
Company Profile for FUSION ANTIBODIES PLC - ORD 4P Share
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
